TransCure bioServices Newsletter

July, 2023

Dear Subscriber,

We have a lot to tell you as Q3 begins: Our 2022/23 webinar series has concluded, we have a new strategic partnership in Korea, and we have several new blog posts for you to read. As always, please feel free to contact us if you have any questions.

WEBINARS!

We've hosted several new webinars this year with Xtalks, and now have a new page on our website with all of them in one place. Topics include: immuno-oncology, infectious diseases, and inflammatory disorders.

NEWS: 

TransCure bioServices and Preclina Inc Join Forces to Expand Collaboration

We have formed a strategic partnership with Preclina, a leading South Korean preclinical research company renowned for its expertise in inflammatory diseases.

BLOGS:

Why CD34+ Humanized Mice Are Dethroning Non-Human Primates in HIV Research

Humanized mice (HIS) are emerging as an alternative model system for studying HIV biology and pathogenesis.

Follow us and share this newsletter on LinkedIn and Twitter